红景天苷调控<italic style="font-style: italic">miRNA-1343-3p/MAP3K6/MMP24</italic>信号分子抑制胃癌细胞的增殖和侵袭

田雨; 王小平; 江锋; 曹晓岚; 侯鑫睿; 张振东

doi:10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2023.0415

您当前的位置：

首页 >

文章列表页 >

红景天苷调控miRNA-1343-3p/MAP3K6/MMP24信号分子抑制胃癌细胞的增殖和侵袭

基础研究 | 更新时间：2024-02-19

- 红景天苷调控miRNA-1343-3p/MAP3K6/MMP24信号分子抑制胃癌细胞的增殖和侵袭
- Salidroside Regulates the miRNA-1343-3p/MAP3K6/MMP24 Signaling Molecules to Inhibit Proliferation and Invasion of Gastric Cancer Cells
- 中山大学学报（医学科学版） 2023年44卷第4期页码：651-662
- 作者机构：
  
  国家民委高原低氧环境与生命健康重点实验室，西藏民族大学医学院，陕西咸阳 712082
- 作者简介：
  
  田雨，研究方向：肿瘤病理学，E - mail：2514459029@qq.com
- 基金信息：
  
  西藏自治区自然科学基金(XZ202101ZR0074G);西藏民族大学重大科研培育专项(20MDT02);2022年度国家级大学生创新创业训练计划支持项目(202210695033);2022 年研究生科研创新与实践项目(Y2022098);陕西省自然科学基金(2020JM-590)
- DOI：10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2023.0415
  中图分类号： R394.2
- 纸质出版日期：2023-07-20，
  
  收稿日期：2023-03-10，
扫描看全文
田雨,王小平,江锋等.红景天苷调控miRNA-1343-3p/MAP3K6/MMP24信号分子抑制胃癌细胞的增殖和侵袭[J].中山大学学报（医学科学版）,2023,44(04):651-662.

TIAN Yu,WANG Xiao-ping,JIANG Feng,et al.Salidroside Regulates the miRNA-1343-3p/MAP3K6/MMP24 Signaling Molecules to Inhibit Proliferation and Invasion of Gastric Cancer Cells[J].Journal of Sun Yat-sen University(Medical Sciences),2023,44(04):651-662.
田雨,王小平,江锋等.红景天苷调控miRNA-1343-3p/MAP3K6/MMP24信号分子抑制胃癌细胞的增殖和侵袭[J].中山大学学报（医学科学版）,2023,44(04):651-662. DOI： 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2023.0415.

TIAN Yu,WANG Xiao-ping,JIANG Feng,et al.Salidroside Regulates the miRNA-1343-3p/MAP3K6/MMP24 Signaling Molecules to Inhibit Proliferation and Invasion of Gastric Cancer Cells[J].Journal of Sun Yat-sen University(Medical Sciences),2023,44(04):651-662. DOI： 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2023.0415.

摘要

目的

本研究旨在探讨红景天苷调控

miR-1343-3p

MAP3K6

（丝裂原激活激酶激酶激酶6）/

MMP24

（膜型基质金属蛋白酶24）信号分子，在抑制胃癌细胞增殖和迁移中的作用。

方法

将人胃癌细胞（MGC-803）按照红景天苷药物浓度不同分为对照组（0 μmol/mL）和低（6 μmol/mL）中（12 μmol/mL）高（24 μmol/mL）红景天苷剂量组；CCK-8实验检测红景天苷药物对人胃癌细胞抗增殖作用；克隆形成实验检测红景天苷药物对人胃癌细胞克隆形成能力的影响；Transwell实验检测红景天苷对人胃癌细胞侵袭能力的影响；细胞划痕实验检测红景天苷对人胃癌细胞迁移能力的影响；高通量测序（RNA-seq）检测了胃癌细胞在红景天苷作用后24 h时对照组和药物组miRNA和mRNA的表达量，将具有明显差异表达的miRNA聚类并预测其靶基因。通过Gene Ontology（GO）和KEGG富集分析，预测差异表达miRNA靶基因的相关功能及相关代谢通路，并建立miRNA与靶基因mRNA间的互作网络。免疫细胞荧光检测相关靶蛋白的表达；q-PCR检测相关候选基因的转录。

结果

CCK-8细胞毒性实验表明，红景天苷抑制了MGC-803细胞的增殖（

0.01）。细胞克隆形成实验表明，红景天苷降低了MGC-803细胞克隆形成能力（

0.000 1）。细胞侵袭实验表明，红景天苷降低了MGC-803细胞侵袭能力（

0.000 1）。划痕实验表明红景天苷降低了细胞迁移能力（

0.000 1）。高通量测序发现红景天苷作用人胃癌细胞后，有44个miRNA的表达量发生了显著差异性变化（

0.05），生物信息学分析结果显示差异表达miRNA所对应的靶mRNA有1 384个，红景天苷作用后引起抑癌因子

miR-1343-3p

表达明显上调（

0.01），而受其调控与增殖和迁移相关的

MAP3K6

和

MMP24

基因转录及表达明显下调（

0.05）。免疫荧光实验证明红景天苷降低了

MAP3K6

和

MMP24

基因的蛋白表达水平（

0.000 1）。q-PCR实验证明红景天苷降低了

MAP3K6

和

MMP24

基因的mRNA表达水平（

0.000 1），而

miR-1343-3p

基因的miRNA表达上调（

0.000 1）。

结论

红景天苷调控

miRNA-1343-3p/MAP3K6/MMP24

信号分子抑制胃癌细胞增殖和侵袭。

Abstract

Objective

The aim of this study is to investigate the role of salidroside in regulating the

miR-1343-3p

MAP3K6

（mitogen-activated protein kinase kinase kinase 6）/

MMP24

（membrane-type matrix metalloproteinase 24） signaling pathway to inhibit gastric cancer cell proliferation and migration.

Methods

Human gastric cancer cells （MGC-803） were divided into several groups based on different salidroside concentrations： a control group （0 μmol/mL）， a low-dose group （6 μmol/mL）， a medium-dose group （12 μmol/mL）， and a high-dose group （24 μmol/mL）. The anti proliferative effects of salidroside on human gastric cancer cells were evaluated by CCK-8 assay. Clonogenic assay was used to examine the effects of salidroside drugs on the clonogenic ability of human gastric cancer cells. Transwell assay was performed to detect the effect of salidroside on the invasive ability of human gastric cancer cells. Cell scratch assay was performed to detect the effect of salidroside on the migration ability of human gastric cancer cells. The miRNA expression profile was analyzed by using RNA-seq in cancer cells for 24 h after salidroside treatment. The differentially expressed miRNAs were clustered and their target genes were predicted. Gene Ontology （GO） and Kyoto Encyclopedia of Genes and Genomes （KEGG） were used to analyze and predict the functions of these target genes， and the interaction networks were established. Immunocytofluorescence was used to detect the expression of target proteins， and the transcription of candidate genes was detected by q-PCR.

Results

CCK-8 cytotoxicity experiments showed that salidroside inhibited the proliferation of MGC-803 cells （

0.01）. Cell cloning experiments showed that salidroside reduced the clonal formation capacity of MGC-803 cells （

0.000 1）. Cell invasion experiments showed that salidroside reduced the MGC-803 cell invasion capacity （

0.000 1）. Cell scratch experiments showed that salidroside reduced the cell migration capacity （

0.000 1）. RNA-seq findings showed that the expression of 44 miRNAs changed significantly after salidroside treatment in cancer cells （

0.05）. Bioinformatic analysis showed that there were 1 384 target mRNAs corresponding to the differentially expressed miRNAs， and the expression of the tumor suppressor

miR-1343-3p

was significantly upregulated after salidroside treatment （

0.01），and resulted in down-regulated transcription of

MAP3K6

and

MMP24

genes which are related to the proliferation and migration of cancer cells （

0.05）. Immunofluorescence experiments demonstrated that salidroside reduced protein expression levels in

MAP3K6

and

MMP24

genes （

0.000 1）. q-PCR experiments showed that salidroside reduced the mRNA expression level of

MAP3K6

and

MMP24

genes （

0.000 1）， while miRNA expression in

miR-1343-3p

gene was upregulated （

0.000 1）.

Conclusion

Salidroside regulates the

miRNA-1343-3p/MAP3K6/MMP24

signaling molecules to inhibit proliferation and invasion of gastric cancer cells.

关键词

微小RNA红景天苷胃癌细胞差异表达调控机制

Keywords

microRNA （miRNA）salidrosidehuman gastric cancer celldifferential expressionregulating mechanism

references

Li K， Zhang A， Li X， et al. Advances in clinical immunotherapy for gastric cancer［J］. Biochim Biophys Acta Rev Cancer， 2021， 1876（2）： 188615.

Zhu L， Liu Z， Ren Y， et al. Neuroprotective effects of salidroside on ageing hippocampal neurons and naturally ageing mice via the PI3K/Akt/TERT pathway［J］. Phytother Res， 2021， 35（10）： 5767-5780.

王翔，杜明奥，徐国友，等. 红景天苷对脂多糖所致痴呆小鼠Tau蛋白过度磷酸化的作用［J］. 遵义医科大学学报， 2023， 46（1）： 52-57.

Wang X， Du MA， Xu GY， et al. Effect of salidroside on lipopolysaccharide-induced overphosphorylation of Tau protein in mice with dementia［J］. J Zunyi Med Univ， 2023， 46（1）： 52-57.

Zhang X， Xie L， Long J， et al. Salidroside： A review of its recent advances in synthetic pathways and pharmacological properties［J］. Chem Biol Interact， 2021， 339： 109268.

Zhang Q， Wang W， Zhou Q， et al. Roles of circRNAs in the tumour microenvironment［J］. Mol Cancer， 2020， 19（1）： 14.

Zhong Y， Du Y， Yang X， et al. Circular RNAs function as ceRNAs to regulate and control human cancer progression［J］. Mol Cancer， 2018， 17（1）： 79.

何志鹏，王洋洋，苏石，等. 早期胃癌保留幽门胃切除术中的淋巴结清扫研究现状状［J］. 中华胃肠外科杂志， 2023， 26（2）： 202-206.

He ZP， Wang YY， Su S， et al. Current status of lymph node dissection in pyloric-preserving gastrectomy for early gastric cancer［J］. Chin J Gastrointest Surg， 2023， 26（2）： 202-206.

Sun X， Xue A， Qi T， et al. Tumor mutational burden is polygenic and genetically associated with complex traits and diseases［J］. Cancer Res， 2021， 81（5）： 1230-1239.

马茹，姬忠贺，张颖，等. 胃肠道癌腹膜转移的核心病理机制［J］. 中华胃肠外科杂志， 2021， 24（3）： 198⁃203.

Ma R， Ji ZX， Zhang Y， et al. Fundamental pathological mechanisms underlying gastro-intestinal cancer peritoneal metastasis［J］. Chin J Gastrointest Surg， 2021， 24（3）： 198⁃203.

Yang L， Yu Y， Zhang Q， et al. Anti-gastric cancer effect of Salidroside through elevating miR-99a expression［J］. Artif Cells Nanomed Biotechnol， 2019， 47（1）： 3500-3510.

Qi Z， Tang T， Sheng L， et al. Salidroside inhibits the proliferation and migration of gastric cancer cells via suppression of Src‑associated signaling pathway activation and heat shock protein 70 expression［J］. Mol Med Rep， 2018， 18（1）： 147-156.

Chen X， Wang J， Xie F， et al. Long noncoding RNA LINC01559 promotes pancreatic cancer progression by acting as a competing endogenous RNA of miR-1343-3p to upregulate RAF1 expression［J］. Aging （Albany NY）， 2020，12（14）： 14452-14466.

Rupaimoole R， Slack F J. MicroRNA therapeutics： towards a new era for the management of cancer and other diseases［J］. Nat Rev Drug Discov， 2017， 16（3）： 203-222.

Wang X， Wang Q， Lin H， et al. Biotherapeutic mechanism of salidroside on gastric carcinoma cells［J］. IOP Conf Ser： Mater Sci and Eng， 2019， 592.

Ahadi A. A systematic review of microRNAs as potential biomarkers for diagnosis and prognosis of gastric cancer［J］. Immunogenetics， 2021， 73（2）： 155-161.

Kim H， Yang J M， Jin Y， et al. MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR， KRAS， and ALK status［J］. Oncotarget， 2017， 8（5）： 8484-8498.

Li H， Liu J， Lai Y， et al. LINC01559 promotes colorectal cancer via sponging miR-1343-3p to modulate PARP1/PTEN/AKT pathway［J］. Pathol Res Pract， 2021， 224： 153521.

Wang L， Bo X， Yi X， et al. Exosome-transferred LINC01559 promotes the progression of gastric cancer via PI3K/AKT signaling pathway［J］. Cell Death Dis， 2020， 11（9）： 723.

Li Y， Zhao Z， Sun D， et al. Novel long noncoding RNA LINC02323 promotes cell growth and migration of ovarian cancer via TGF-beta receptor 1 by miR-1343-3p［J］. J Clin Lab Anal， 2021， 35（2）： e23651.

Bhat I P， Rather T B， Bhat G A， et al. TEAD4 nuclear localization and regulation by miR-4269 and miR-1343-3p in colorectal carcinoma［J］. Pathol Res Pract， 2022， 231： 153791.

Eto N， Miyagishi M， Inagi R， et al. Mitogen-activated protein 3 kinase 6 mediates angiogenic and tumorigenic effects via vascular endothelial growth factor expression［J］. Am J Pathol， 2009， 174（4）： 1553-1563.

Gaston D， Hansford S， Oliveira C， et al. Germline mutations in MAP3K6 are associated with familial gastric cancer［J］. PLoS Genet， 2014， 10（10）： e1004669.

Guccini I， Revandkar A， D'Ambrosio M， et al. Senescence reprogramming by TIMP1 deficiency promotes prostate cancer metastasis［J］. Cancer Cell， 2021， 39（1）： 68-82.

Rohani MG， Parks WC. Matrix remodeling by MMPs during wound repair［J］. Matrix Biol， 2015， 44-46： 113-121.

Egeblad M， Werb Z. New functions for the matrix metalloproteinases in cancer progression［J］. Nat Rev Cancer， 2002， 2（3）： 161-174.

de la Pena S， Sampieri C L， Ochoa-Lara M， et al. Expression of the matrix metalloproteases 2， 14， 24， and 25 and tissue inhibitor 3 as potential molecular markers in advanced human gastric cancer［J］. Dis Markers， 2014， 2014： 285906.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据

红景天苷调控miRNA-1343-3p/MAP3K6/MMP24信号分子抑制胃癌细胞的增殖和侵袭

Salidroside Regulates the miRNA-1343-3p/MAP3K6/MMP24 Signaling Molecules to Inhibit Proliferation and Invasion of Gastric Cancer Cells

DOI：10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2023.0415

摘要

Abstract

关键词

Keywords

references